Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease
Summary Sporadic Creutzfeldt-Jakob disease is a fatal neurodegenerative disease caused
by misfolded prion proteins (PrP Sc). Effective therapeutics are currently not available and …
by misfolded prion proteins (PrP Sc). Effective therapeutics are currently not available and …
Neurofilaments as biomarkers in neurological disorders
M Khalil, CE Teunissen, M Otto, F Piehl… - Nature Reviews …, 2018 - nature.com
Neuroaxonal damage is the pathological substrate of permanent disability in various
neurological disorders. Reliable quantification and longitudinal follow-up of such damage …
neurological disorders. Reliable quantification and longitudinal follow-up of such damage …
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser… - Nature medicine, 2019 - nature.com
Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for
various cerebral proteopathies. Here we leverage the unique characteristics of the …
various cerebral proteopathies. Here we leverage the unique characteristics of the …
[HTML][HTML] Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE …
C Darryl, E Bertini, KJ Swoboda, WL Hwu… - Neuromuscular …, 2019 - Elsevier
Spinal muscular atrophy (SMA) is a neurodegenerative disease associated with severe
muscle atrophy and weakness in the limbs and trunk. We report interim efficacy and safety …
muscle atrophy and weakness in the limbs and trunk. We report interim efficacy and safety …
Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder
Objective: To determine if blood neurofilament light chain (NfL) protein can discriminate
between Parkinson disease (PD) and atypical parkinsonian disorders (APD) with equally …
between Parkinson disease (PD) and atypical parkinsonian disorders (APD) with equally …
[HTML][HTML] Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and …
D Jiang, F Gong, X Ge, C Lv, C Huang, S Feng… - Journal of …, 2020 - Springer
Background Spinal cord injury (SCI) is a catastrophic injury that can cause irreversible motor
dysfunction with high disability. Exosomes participate in the transport of miRNAs and play an …
dysfunction with high disability. Exosomes participate in the transport of miRNAs and play an …
[HTML][HTML] Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases
M Bacioglu, LF Maia, O Preische, J Schelle, A Apel… - Neuron, 2016 - cell.com
A majority of current disease-modifying therapeutic approaches for age-related
neurodegenerative diseases target their characteristic proteopathic lesions (α-synuclein …
neurodegenerative diseases target their characteristic proteopathic lesions (α-synuclein …
Plasma biomarkers of astrocytic and neuronal dysfunction in early-and late-onset Alzheimer's disease
Introduction We investigated plasma proteomic markers of astrocytopathy, brain
degeneration, plasticity, and inflammation in sporadic early-onset versus late-onset …
degeneration, plasticity, and inflammation in sporadic early-onset versus late-onset …
Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease
WW Aamodt, T Waligorska, J Shen… - Movement …, 2021 - Wiley Online Library
Background Neurofilament light chain protein (NfL) is a promising biomarker of
neurodegeneration. Objectives To determine whether plasma and CSF NfL (1) associate …
neurodegeneration. Objectives To determine whether plasma and CSF NfL (1) associate …
Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis
Objective: To test blood and CSF neurofilament light chain (NfL) levels in relation to disease
progression and survival in amyotrophic lateral sclerosis (ALS). Methods: Using an …
progression and survival in amyotrophic lateral sclerosis (ALS). Methods: Using an …